Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes | MicrobiomeTrials← Back to trialsNCT07640139
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2029-12-31
Enrollment target: 125,000 participants Locations- Indiana University, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
ObesityDiabetesMetabolic Disorders
Background:
Diabetes and obesity are chronic diseases. They can affect blood flow and how the body processes nutrients,…
Bethesda, United StatesEst. completion Nov 30, 2054
Gestational Weight Gain
It is widely recognized that nutrition, metabolism and physical activity during pregnancy play a central role in several…
Trieste, ItalyEst. completion Nov 30, 2026
Recruiting
Venous Thromboembolism (VTE)Post Partum Women
Venous thromboembolism (VTE) is currently the second cause of death in women of reproductive age worldwide. The incidenc…
Amiens, FranceEst. completion May 16, 2028